colforsin has been researched along with Respiratory Syncytial Virus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Davis, IC; Matalon, S; Schwiebert, E; Shrestha, K; Song, W; Sullender, WM | 1 |
| Davis, IC; Factor, P; Gao, Z; Hickman-Davis, JM; Matalon, S; Sullender, WM; Xu, A | 1 |
2 other study(ies) available for colforsin and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Inhibition of Na+ transport in lung epithelial cells by respiratory syncytial virus infection.
Topics: Animals; Biological Transport; Biological Transport, Active; Cell Line; Colforsin; Epithelial Cells; Epithelial Sodium Channels; Fluorescent Antibody Technique; Humans; Ion Channel Gating; Lung; Mice; Protein Subunits; Purines; Pyrimidines; Respiratory Syncytial Virus Infections; Sodium; Terbutaline; Trachea; Uridine Triphosphate | 2009 |
Respiratory syncytial virus induces insensitivity to beta-adrenergic agonists in mouse lung epithelium in vivo.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Catecholamines; Chemokine CXCL1; Chemokines, CXC; Colforsin; Extravascular Lung Water; Female; Male; Mice; Mice, Inbred BALB C; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Pulmonary Alveoli; Receptors, Adrenergic, beta-2; Respiratory Mucosa; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Specific Pathogen-Free Organisms; Terbutaline | 2007 |